A detailed history of Sfe Investment Counsel transactions in Zoetis Inc. stock. As of the latest transaction made, Sfe Investment Counsel holds 26,947 shares of ZTS stock, worth $5.12 Million. This represents 1.07% of its overall portfolio holdings.

Number of Shares
26,947
Previous 23,267 15.82%
Holding current value
$5.12 Million
Previous $3.94 Million 18.64%
% of portfolio
1.07%
Previous 0.91%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$145.54 - $178.83 $535,587 - $658,094
3,680 Added 15.82%
26,947 $4.67 Million
Q1 2024

May 03, 2024

BUY
$165.67 - $199.94 $1.37 Million - $1.65 Million
8,254 Added 54.98%
23,267 $3.94 Million
Q4 2023

Jan 31, 2024

BUY
$151.44 - $200.09 $15,144 - $20,009
100 Added 0.67%
15,013 $2.96 Million
Q3 2023

Oct 24, 2023

BUY
$167.14 - $192.77 $215,944 - $249,058
1,292 Added 9.49%
14,913 $2.59 Million
Q2 2023

Jul 24, 2023

BUY
$160.94 - $186.23 $155,628 - $180,084
967 Added 7.64%
13,621 $2.35 Million
Q1 2023

May 08, 2023

BUY
$145.48 - $175.02 $101,690 - $122,338
699 Added 5.85%
12,654 $2.11 Million
Q4 2022

Feb 09, 2023

SELL
$131.14 - $157.47 $45,767 - $54,957
-349 Reduced 2.84%
11,955 $1.75 Million
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $77,852 - $95,838
525 Added 4.46%
12,304 $1.83 Million
Q2 2022

Aug 10, 2022

BUY
$155.97 - $200.09 $308,352 - $395,577
1,977 Added 20.17%
11,779 $2.03 Million
Q1 2022

May 06, 2022

BUY
$181.39 - $234.03 $613,642 - $791,723
3,383 Added 52.7%
9,802 $1.85 Million
Q4 2021

Feb 07, 2022

SELL
$193.69 - $247.03 $77,863 - $99,306
-402 Reduced 5.89%
6,419 $1.57 Million
Q3 2021

Nov 12, 2021

SELL
$189.29 - $209.69 $5,678 - $6,290
-30 Reduced 0.44%
6,821 $1.32 Million
Q2 2021

Aug 10, 2021

BUY
$155.9 - $187.99 $8,574 - $10,339
55 Added 0.81%
6,851 $1.28 Million
Q1 2021

Apr 30, 2021

BUY
$144.0 - $169.39 $96,480 - $113,491
670 Added 10.94%
6,796 $1.07 Million
Q4 2020

Feb 04, 2021

BUY
$157.07 - $174.35 $1,099 - $1,220
7 Added 0.11%
6,126 $1.01 Million
Q3 2020

Nov 09, 2020

BUY
$137.1 - $165.37 $3,153 - $3,803
23 Added 0.38%
6,119 $1.01 Million
Q2 2020

Aug 05, 2020

SELL
$111.92 - $142.53 $80,246 - $102,194
-717 Reduced 10.52%
6,096 $835,000
Q1 2020

May 04, 2020

SELL
$92.66 - $144.94 $17,142 - $26,813
-185 Reduced 2.64%
6,813 $802,000
Q4 2019

Jan 17, 2020

SELL
$116.25 - $133.25 $2,906 - $3,331
-25 Reduced 0.36%
6,998 $926,000
Q3 2019

Oct 31, 2019

SELL
$112.57 - $128.43 $61,913 - $70,636
-550 Reduced 7.26%
7,023 $875,000
Q2 2019

Jul 26, 2019

SELL
$97.98 - $114.28 $7,446 - $8,685
-76 Reduced 0.99%
7,573 $859,000
Q1 2019

May 08, 2019

SELL
$81.56 - $100.67 $282,442 - $348,620
-3,463 Reduced 31.16%
7,649 $770,000
Q4 2018

Feb 07, 2019

BUY
$79.28 - $95.27 $102,271 - $122,898
1,290 Added 13.13%
11,112 $951,000
Q3 2018

Oct 31, 2018

SELL
$83.5 - $93.23 $17,368 - $19,391
-208 Reduced 2.07%
9,822 $899,000
Q2 2018

Jul 30, 2018

BUY
$79.9 - $89.2 $157,562 - $175,902
1,972 Added 24.47%
10,030 $854,000
Q1 2018

May 01, 2018

BUY
$71.51 - $84.69 $19,879 - $23,543
278 Added 3.57%
8,058 $673,000
Q4 2017

Feb 06, 2018

BUY
$63.24 - $72.8 $6,956 - $8,008
110 Added 1.43%
7,780 $560,000
Q3 2017

Nov 01, 2017

BUY
$59.73 - $65.4 $458,129 - $501,618
7,670
7,670 $489,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $88.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Sfe Investment Counsel Portfolio

Follow Sfe Investment Counsel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sfe Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Sfe Investment Counsel with notifications on news.